Search results
Sharpless is married with two children. Sharpless' wife, Julie Sharpless, worked as a physician and associate professor at the University of North Carolina . Sharpless currently lives in Washington, D.C.
Dr. Norman E. “Ned” Sharpless was officially sworn in as the 15. th. Director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his appointment, Dr. Sharpless served as the Director of the Lineberger Comprehensive Cancer Center at the University of North Carolina (UNC), a position he held since 2014.
Apr 4, 2022 · Norman “Ned” Sharpless, the director of the National Cancer Institute who had a short stint leading the Food and Drug Administration, announced Monday that he is stepping down at the end of ...
- Laurie Mcginley
Apr 4, 2022 · Norman E. “Ned” Sharpless, M.D., announced today that he has decided to step down from his position as director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he has held since 2017. Dr. Sharpless will continue as NCI director through April 29, 2022, to allow for a thorough transition.
Oct 18, 2017 · Norman E. Sharpless, MD, accompanied by his wife, Julie Sharpless, MD, is sworn in as NCI director by Acting Secretary of Health and Human Services Eric D. Hargan. Norman E. “Ned” Sharpless, MD, was sworn in as the 15th director of the National Cancer Institute (NCI) on Tuesday.
Norman Sharpless, MD, is a physician, scientist, entrepreneur, and former federal official. He served as director of the National Cancer Institute from 2017 to 2022, and as acting commissioner of the US Food and Drug Administration in 2019. Prior to government, Dr. Sharpless was director of the Lineberger Comprehensive Cancer Center at UNC. He ...
Mar 16, 2019 · Gottlieb announced his resignation on March 5, saying he wants to spend more time with his wife and children, who live in Connecticut. Sharpless joined NCI in October 2017. During his short time at the institute, Sharpless worked to enhance data sharing and modernize clinical trials for new cancer treatments.
